← Leaderboards
Nigel H. Greig
Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAgingS DiseaseAnalogIn VivoNeurodegenerative DisordersNeuronsPre-ClinicalElderlyBrainClinical TrialsPharmaceutical PreparationsClinicStrokeDesignInflammationNeurologicNerve DegenerationTranslatingDrug DevelopmentParkinson DiseaseChronicClinical ResearchTranslations
Grant awards (59)
Pro-inflammatory cytokine lowering anti-inflammatory drugs$1,440,686
ZIA · FY2025 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development$529,901
ZIA · FY2025 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease)$397,426
ZIA · FY2025 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)$331,188
ZIA · FY2025 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$2,323,536
ZIA · FY2024 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development$902,370
ZIA · FY2024 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease)$613,612
ZIA · FY2024 · AG · contact PI
ALZHEIMERS RESEARCH PROJECT: Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)$523,375
ZIA · FY2024 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$2,166,049
ZIA · FY2023 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)$1,225,528
ZIA · FY2023 · AG · contact PI
Alzheimer's disease drug development$715,227
ZIA · FY2023 · AG · contact PI
Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease)$715,227
ZIA · FY2023 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$2,106,657
ZIA · FY2022 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)$251,332
ZIA · FY2022 · AG · contact PI
Alzheimer's disease drug development$240,161
ZIA · FY2022 · AG · contact PI
Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease)$139,629
ZIA · FY2022 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$1,864,880
ZIA · FY2021 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$971,839
ZIA · FY2021 · AG · contact PI
Design And Development Of Experimental Therapeutics$893,041
ZIA · FY2021 · AG · contact PI
Alzheimer's disease drug development$694,239
ZIA · FY2021 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$2,115,683
ZIA · FY2020 · AG · contact PI
Alzheimer's disease drug development$1,428,086
ZIA · FY2020 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$1,019,063
ZIA · FY2020 · AG · contact PI
Design And Development Of Experimental Therapeutics$853,810
ZIA · FY2020 · AG · contact PI
Alzheimer's disease drug development$2,163,807
ZIA · FY2019 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$1,406,475
ZIA · FY2019 · AG · contact PI
Design And Development Of Experimental Therapeutics$811,428
ZIA · FY2019 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$765,761
ZIA · FY2019 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$1,728,312
ZIA · FY2018 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,090,483
ZIA · FY2018 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$563,293
ZIA · FY2018 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$1,308,542
ZIA · FY2017 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,247,204
ZIA · FY2017 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$981,407
ZIA · FY2017 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$751,361
ZIA · FY2016 · AG · contact PI
Design And Development Of Experimental Therapeutics$601,089
ZIA · FY2016 · AG · contact PI
Pro-inflammatory cytokine lowering anti-inflammatory drugs$325,590
ZIA · FY2016 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,279,633
ZIA · FY2015 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$1,010,237
ZIA · FY2015 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,266,468
ZIA · FY2014 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$379,940
ZIA · FY2014 · AG · contact PI
Design And Development Of Experimental Therapeutics$958,195
ZIA · FY2013 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$387,841
ZIA · FY2013 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,951,021
ZIA · FY2012 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$634,082
ZIA · FY2012 · AG · contact PI
Design And Development Of Experimental Therapeutics$1,610,701
ZIA · FY2011 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$471,425
ZIA · FY2011 · AG · contact PI
Design And Development Of Experimental Therapeutics$784,982
ZIA · FY2010 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$303,864
ZIA · FY2010 · AG · contact PI
Design And Development Of Experimental Therapeutics$814,403
ZIA · FY2009 · AG · contact PI
Neuroprotective role of GLP-1 receptor agonists$352,174
ZIA · FY2009 · AG · contact PI
Design And Development Of Experimental Therapeutics$943,412
Z01 · FY2008 · AG · contact PI
Design And Development Of Experimental Therapeutics$781,688
Z01 · FY2007 · AG · contact PI
Design And Development Of Experimental Therapeutics$0
Z01 · FY2006 · AG · contact PI
Design And Development Of Experimental Therapeutics$0
Z01 · FY2005 · AG
Design And Development Of Experimental Therapeutics$0
Z01 · FY2004 · AG
Design And Development Of Experimental Therapeutics$0
Z01 · FY2003 · AG
Design And Development Of Experimental Therapeutics$0
Z01 · FY2002 · AG
Design And Development Of Experimental Therapeutics$0
Z01 · FY2001 · AG